FDA guideline on BE, draft August 2021 [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2021-08-24 01:46 (1356 d 13:15 ago) – Posting: # 22535
Views: 4,232

Hi Achievwin,

❝ FDA decided to split BA/BE guidance into two guidance 1) for ANDA filings and 2) for IND/NDAs


Already in 2013/2014.

❝ More elaborate explanations of each aspect.


I expect to see an update of #2 (current draft of Feb 2019) as well.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
125 visitors (0 registered, 125 guests [including 7 identified bots]).
Forum time: 15:01 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5